Report Focuses on VC Investments of Life Science Companies

Biotechnology and pharmaceuticals were the top areas for investment, with around 30% going to each area. The therapeutic areas of oncology, neurology and infectious diseases saw the most investment.

A new report on the venture capital investments of global life science companies said the US continues to dominate investment by venture capital firms.

The report, Investment Criteria of Corporate Venture Capital in the Life Science Industry, is based on the 300 most recent investments of the 19 biggest private equity investment companies over the past decade.

The findings revealed that 189 firms in the US won 67% of the venture capital funding. Europe also had a good number of investments, especially in the UK (20 companies; 7%) and Switzerland (15 companies; 5%).

Biotechnology and pharmaceuticals were the top areas for investment, with ar